Form 8-K - Current report:
SEC Accession No. 0000950170-25-043869
Filing Date
2025-03-24
Accepted
2025-03-24 16:25:08
Documents
13
Period of Report
2025-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20250324.htm   iXBRL 8-K 45019
2 EX-99.1 bolt-ex99_1.htm EX-99.1 350256
3 GRAPHIC img192637872_0.jpg GRAPHIC 12154
  Complete submission text file 0000950170-25-043869.txt   547421

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20250324.xsd EX-101.SCH 25969
15 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20250324_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 25764473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)